ImageneBio, Inc.
IMA
$5.83
-$0.19-3.16%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | 119.47% | 568.44% | -10.69% | 12.54% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 38.46% | 380.38% | 15.25% | -69.72% | |
| Operating Income | -38.46% | -1,206.19% | -15.25% | 73.28% | |
| Income Before Tax | -49.70% | -680.80% | -21.19% | 72.77% | |
| Income Tax Expenses | -2,223.08% | -- | -- | -- | |
| Earnings from Continuing Operations | -43.56% | -678.48% | -21.19% | 72.77% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -43.56% | -678.48% | -21.19% | 72.77% | |
| EBIT | -38.46% | -1,206.19% | -15.25% | 73.28% | |
| EBITDA | -32.45% | -1,255.35% | -23.94% | 72.56% | |
| EPS Basic | 54.08% | 31.90% | -9,611.24% | 74.71% | |
| Normalized Basic EPS | 21.68% | -28.25% | -- | 81.11% | |
| EPS Diluted | 54.08% | 31.90% | -9,611.24% | 74.71% | |
| Normalized Diluted EPS | 21.68% | -28.25% | -- | 81.11% | |
| Average Basic Shares Outstanding | 91.12% | 508.80% | -- | 43.76% | |
| Average Diluted Shares Outstanding | 91.12% | 508.80% | -99.56% | 43.76% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |